跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Norsalin-D - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Norsalin-D
Approved
STANDARD
Norsalin-D
Otsuka Pharmaceutical India Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
13eef58dbb6bdd64
Company
Otsuka Pharmaceutical India Private Limited
Type
Standard
Approval Details
Approval Id
13eef58dbb6bdd64
Drug Approval Philippines Name
Norsalin-D
Product Name
Norsalin-D
Registration Number
DR-XY36771
Brand Name
Norsalin-D
Generic Name
5% Dextrose in 0.9% Sodium Chloride
Dosage Form
Solution For Iv Infusion
Dosage Strength
50mg/ 9 mg per mL (5%w/v / 0.9% w/v
Manufacturer
Otsuka Pharmaceutical India Private Limited
Importer
Otsuka (Phils.) Pharmaceutical, Inc.
Distributor
Otsuka (Phils.) Pharmaceutical, Inc.
Issuance Date
27 October 2024
Expiry Date
12 October 2029
Pharmacologic Category
Electrolyte
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
13eef58dbb6bdd64
Type
Standard
Back to Philippines FDA Approvals